iShares Nasdaq Biotechnology ETF (IBB) Shares Bought by Benjamin F. Edwards & Company Inc.

Benjamin F. Edwards & Company Inc. lifted its stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 636.4% in the 3rd quarter, Holdings Channel reports. The firm owned 891 shares of the financial services provider’s stock after buying an additional 770 shares during the quarter. Benjamin F. Edwards & Company Inc.’s holdings in iShares Nasdaq Biotechnology ETF were worth $109,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently modified their holdings of the company. Ruggie Capital Group increased its stake in shares of iShares Nasdaq Biotechnology ETF by 1.2% during the 2nd quarter. Ruggie Capital Group now owns 37,489 shares of the financial services provider’s stock worth $4,117,000 after purchasing an additional 441 shares during the last quarter. Northstar Group Inc. increased its stake in shares of iShares Nasdaq Biotechnology ETF by 5.5% during the 2nd quarter. Northstar Group Inc. now owns 8,680 shares of the financial services provider’s stock worth $920,000 after purchasing an additional 450 shares during the last quarter. Bartlett & Co. LLC increased its stake in shares of iShares Nasdaq Biotechnology ETF by 4.5% during the 3rd quarter. Bartlett & Co. LLC now owns 10,736 shares of the financial services provider’s stock worth $1,309,000 after purchasing an additional 462 shares during the last quarter. CIBC Private Wealth Group LLC increased its stake in shares of iShares Nasdaq Biotechnology ETF by 0.8% during the 2nd quarter. CIBC Private Wealth Group LLC now owns 60,936 shares of the financial services provider’s stock worth $6,692,000 after purchasing an additional 467 shares during the last quarter. Finally, Janney Montgomery Scott LLC increased its stake in shares of iShares Nasdaq Biotechnology ETF by 0.6% during the 2nd quarter. Janney Montgomery Scott LLC now owns 76,623 shares of the financial services provider’s stock worth $8,415,000 after purchasing an additional 469 shares during the last quarter. Institutional investors own 65.86% of the company’s stock.

Shares of IBB stock opened at $108.10 on Friday. iShares Nasdaq Biotechnology ETF has a 12-month low of $100.22 and a 12-month high of $122.97.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Further Reading: What are the benefits of a balanced fund?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply